Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVALTRA study of anidulafungin versus liposomal amphotericin B prophylaxis in high-risk liver transplant patients
2011-000804-17Phase 4Completed
- Sponsor
- Fundación SEIMC-GeSIDA
- Start
- Sep 2011
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Cyclic Peptides → Modified Peptides → Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in invasive mycoses and candidiasis comparing Anidulafungin prophylaxis with Liposomal amphotericin B prophylaxis (2 arms). Primary endpoints: Renal impairment or deterioration of baseline renal function and Infusion-related adverse events. Started Sep 2011; status: completed.
02
Drugs
anidulafunginliposomal amphotericin b
03
Conditions
invasive mycosescandidiasis
Beyond the preview
Go deeper on 2011-000804-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000804-17.